Datasets:

Taylor658
/

stereotactic-radiosurgery-k1-with-segmentation

Modalities:

Tabular

Text

Formats:

Size:

Libraries:

Dataset card Data Studio Files Files and versions Community

Dataset Viewer

Auto-converted to Parquet

Split (1)

train · 400 rows

Patient_ID stringlengths 8 8	Age int64 18 89	Gender stringclasses 2 values	Weight_kg float64 50.2 100	Height_cm float64 150 200	Comorbidities stringclasses 4 values	Previous_Treatments stringclasses 3 values	Tumor_Histology stringclasses 4 values	Tumor_Grade stringclasses 3 values	Tumor_Stage stringclasses 4 values	Imaging_Modality stringclasses 3 values	Image_Resolution stringclasses 2 values	Scan_Type stringclasses 2 values	Scanner_Manufacturer stringclasses 3 values	Gross_Tumor_Volume_cm3 float64 1.22 150	Clinical_Target_Volume_cm3 float64 0.96 200	Planning_Target_Volume_cm3 float64 1.47 249	Beam_Arrangements stringclasses 2 values	Dose_Distributions_Gy float64 10.2 99.8	Optimization_Objectives stringclasses 3 values	Dose_Volume_Histogram stringlengths 9 9	Synthetic_Image_Path stringlengths 41 41	GTV_Segmentation_Path stringlengths 45 45	CTV_Segmentation_Path stringlengths 45 45	PTV_Segmentation_Path stringlengths 45 45
SIM-0001	36	Male	67.6	155.7	Hypertension	Surgery	Meningioma	Low	III	PET	Isotropic	Contrast-Enhanced	Siemens	148.73	29.01	143.24	Single	35.04	Maximize Tumor Dose	DVH_P0001	/simulated/path/P0001_synthetic_image.nii	/simulated/path/SIM-0001_GTV_segmentation.nii	/simulated/path/SIM-0001_CTV_segmentation.nii	/simulated/path/SIM-0001_PTV_segmentation.nii
SIM-0002	20	Female	62.7	178.3	Hypertension	Radiotherapy	Glioblastoma	Intermediate	II	MRI	Anisotropic	Non-Contrast-Enhanced	Philips	72.72	74.71	212.1	Single	91.26	Balanced	DVH_P0002	/simulated/path/P0002_synthetic_image.nii	/simulated/path/SIM-0002_GTV_segmentation.nii	/simulated/path/SIM-0002_CTV_segmentation.nii	/simulated/path/SIM-0002_PTV_segmentation.nii
SIM-0003	65	Female	74.6	171	Hypertension	null	Metastatic	High	III	PET	Anisotropic	Contrast-Enhanced	Siemens	111.56	167.26	153.63	Single	70.64	Maximize Tumor Dose	DVH_P0003	/simulated/path/P0003_synthetic_image.nii	/simulated/path/SIM-0003_GTV_segmentation.nii	/simulated/path/SIM-0003_CTV_segmentation.nii	/simulated/path/SIM-0003_PTV_segmentation.nii
SIM-0004	57	Female	90	187.5	null	Surgery	Astrocytoma	Intermediate	III	PET	Anisotropic	Contrast-Enhanced	Philips	115.48	143.11	11.71	Single	84.85	Organ-Sparing	DVH_P0004	/simulated/path/P0004_synthetic_image.nii	/simulated/path/SIM-0004_GTV_segmentation.nii	/simulated/path/SIM-0004_CTV_segmentation.nii	/simulated/path/SIM-0004_PTV_segmentation.nii
SIM-0005	86	Female	91.3	165.8	Cardiac Issues	null	Glioblastoma	Low	II	MRI	Anisotropic	Non-Contrast-Enhanced	Philips	47.73	14.87	78.38	Multi-Beam	45.22	Organ-Sparing	DVH_P0005	/simulated/path/P0005_synthetic_image.nii	/simulated/path/SIM-0005_GTV_segmentation.nii	/simulated/path/SIM-0005_CTV_segmentation.nii	/simulated/path/SIM-0005_PTV_segmentation.nii
SIM-0006	80	Female	73.5	152.7	Hypertension	Radiotherapy	Astrocytoma	Intermediate	II	MRI	Anisotropic	Non-Contrast-Enhanced	Philips	110.17	68.01	43.6	Multi-Beam	74.06	Balanced	DVH_P0006	/simulated/path/P0006_synthetic_image.nii	/simulated/path/SIM-0006_GTV_segmentation.nii	/simulated/path/SIM-0006_CTV_segmentation.nii	/simulated/path/SIM-0006_PTV_segmentation.nii
SIM-0007	61	Female	66.3	172.9	null	Chemotherapy	Meningioma	High	IV	CT	Isotropic	Non-Contrast-Enhanced	Philips	31.25	189.54	44.62	Multi-Beam	97.29	Maximize Tumor Dose	DVH_P0007	/simulated/path/P0007_synthetic_image.nii	/simulated/path/SIM-0007_GTV_segmentation.nii	/simulated/path/SIM-0007_CTV_segmentation.nii	/simulated/path/SIM-0007_PTV_segmentation.nii
SIM-0008	50	Female	94.9	195.7	Diabetes	Chemotherapy	Astrocytoma	High	I	CT	Isotropic	Non-Contrast-Enhanced	Philips	56.38	197.43	234.48	Single	45.66	Maximize Tumor Dose	DVH_P0008	/simulated/path/P0008_synthetic_image.nii	/simulated/path/SIM-0008_GTV_segmentation.nii	/simulated/path/SIM-0008_CTV_segmentation.nii	/simulated/path/SIM-0008_PTV_segmentation.nii
SIM-0009	84	Female	58	184.8	Cardiac Issues	Radiotherapy	Metastatic	Intermediate	I	PET	Anisotropic	Non-Contrast-Enhanced	Philips	117.83	56.97	245.46	Multi-Beam	68.41	Maximize Tumor Dose	DVH_P0009	/simulated/path/P0009_synthetic_image.nii	/simulated/path/SIM-0009_GTV_segmentation.nii	/simulated/path/SIM-0009_CTV_segmentation.nii	/simulated/path/SIM-0009_PTV_segmentation.nii
SIM-0010	28	Male	93.8	192.9	Hypertension	Chemotherapy	Metastatic	Low	IV	CT	Isotropic	Contrast-Enhanced	Siemens	135.13	101.51	142.62	Single	60.7	Balanced	DVH_P0010	/simulated/path/P0010_synthetic_image.nii	/simulated/path/SIM-0010_GTV_segmentation.nii	/simulated/path/SIM-0010_CTV_segmentation.nii	/simulated/path/SIM-0010_PTV_segmentation.nii
SIM-0011	87	Female	55.8	182.8	Cancer History	Chemotherapy	Meningioma	Intermediate	IV	PET	Isotropic	Non-Contrast-Enhanced	Siemens	73.37	118.87	7.26	Single	90.98	Maximize Tumor Dose	DVH_P0011	/simulated/path/P0011_synthetic_image.nii	/simulated/path/SIM-0011_GTV_segmentation.nii	/simulated/path/SIM-0011_CTV_segmentation.nii	/simulated/path/SIM-0011_PTV_segmentation.nii
SIM-0012	83	Male	80.1	169.5	Hypertension	Surgery	Glioblastoma	Intermediate	III	CT	Anisotropic	Non-Contrast-Enhanced	Siemens	144.12	162.91	190.12	Single	54.94	Organ-Sparing	DVH_P0012	/simulated/path/P0012_synthetic_image.nii	/simulated/path/SIM-0012_GTV_segmentation.nii	/simulated/path/SIM-0012_CTV_segmentation.nii	/simulated/path/SIM-0012_PTV_segmentation.nii
SIM-0013	64	Male	92.1	172.1	Cancer History	Surgery	Glioblastoma	Low	IV	CT	Anisotropic	Contrast-Enhanced	Siemens	78.47	55.83	221.58	Single	81.78	Organ-Sparing	DVH_P0013	/simulated/path/P0013_synthetic_image.nii	/simulated/path/SIM-0013_GTV_segmentation.nii	/simulated/path/SIM-0013_CTV_segmentation.nii	/simulated/path/SIM-0013_PTV_segmentation.nii
SIM-0014	88	Female	88.9	162.9	Diabetes	Radiotherapy	Metastatic	High	II	CT	Isotropic	Contrast-Enhanced	GE	15.93	131.69	236.14	Multi-Beam	76.93	Balanced	DVH_P0014	/simulated/path/P0014_synthetic_image.nii	/simulated/path/SIM-0014_GTV_segmentation.nii	/simulated/path/SIM-0014_CTV_segmentation.nii	/simulated/path/SIM-0014_PTV_segmentation.nii
SIM-0015	86	Female	69.1	180.7	Hypertension	Chemotherapy	Glioblastoma	Intermediate	IV	CT	Anisotropic	Non-Contrast-Enhanced	Siemens	10.75	28.74	204.99	Multi-Beam	66.99	Balanced	DVH_P0015	/simulated/path/P0015_synthetic_image.nii	/simulated/path/SIM-0015_GTV_segmentation.nii	/simulated/path/SIM-0015_CTV_segmentation.nii	/simulated/path/SIM-0015_PTV_segmentation.nii
SIM-0016	21	Female	63.7	160.5	null	Chemotherapy	Metastatic	Intermediate	II	CT	Isotropic	Non-Contrast-Enhanced	GE	21.62	63.02	152.55	Single	66.62	Balanced	DVH_P0016	/simulated/path/P0016_synthetic_image.nii	/simulated/path/SIM-0016_GTV_segmentation.nii	/simulated/path/SIM-0016_CTV_segmentation.nii	/simulated/path/SIM-0016_PTV_segmentation.nii
SIM-0017	71	Female	50.8	178.2	null	Chemotherapy	Meningioma	Intermediate	IV	MRI	Isotropic	Contrast-Enhanced	GE	144.99	15.16	133.71	Single	57.55	Organ-Sparing	DVH_P0017	/simulated/path/P0017_synthetic_image.nii	/simulated/path/SIM-0017_GTV_segmentation.nii	/simulated/path/SIM-0017_CTV_segmentation.nii	/simulated/path/SIM-0017_PTV_segmentation.nii
SIM-0018	47	Male	60.3	177.6	Cancer History	Surgery	Astrocytoma	Intermediate	III	CT	Isotropic	Contrast-Enhanced	Philips	43.59	113.7	115.86	Multi-Beam	39.81	Maximize Tumor Dose	DVH_P0018	/simulated/path/P0018_synthetic_image.nii	/simulated/path/SIM-0018_GTV_segmentation.nii	/simulated/path/SIM-0018_CTV_segmentation.nii	/simulated/path/SIM-0018_PTV_segmentation.nii
SIM-0019	33	Male	96.3	155.2	Hypertension	Chemotherapy	Astrocytoma	Intermediate	III	CT	Anisotropic	Non-Contrast-Enhanced	Philips	18.91	82.48	201.4	Multi-Beam	81.72	Organ-Sparing	DVH_P0019	/simulated/path/P0019_synthetic_image.nii	/simulated/path/SIM-0019_GTV_segmentation.nii	/simulated/path/SIM-0019_CTV_segmentation.nii	/simulated/path/SIM-0019_PTV_segmentation.nii
SIM-0020	78	Female	83.4	160.7	Diabetes	Chemotherapy	Metastatic	Intermediate	II	CT	Isotropic	Contrast-Enhanced	GE	83.96	87.85	151.66	Multi-Beam	55.09	Organ-Sparing	DVH_P0020	/simulated/path/P0020_synthetic_image.nii	/simulated/path/SIM-0020_GTV_segmentation.nii	/simulated/path/SIM-0020_CTV_segmentation.nii	/simulated/path/SIM-0020_PTV_segmentation.nii
SIM-0021	35	Male	60	188.2	Hypertension	Chemotherapy	Meningioma	Intermediate	IV	MRI	Anisotropic	Non-Contrast-Enhanced	Siemens	3.65	95.52	118.49	Multi-Beam	57.21	Organ-Sparing	DVH_P0021	/simulated/path/P0021_synthetic_image.nii	/simulated/path/SIM-0021_GTV_segmentation.nii	/simulated/path/SIM-0021_CTV_segmentation.nii	/simulated/path/SIM-0021_PTV_segmentation.nii
SIM-0022	60	Male	57.8	152.3	Diabetes	Chemotherapy	Meningioma	High	I	MRI	Isotropic	Contrast-Enhanced	GE	119.27	39.03	92.61	Single	36.59	Maximize Tumor Dose	DVH_P0022	/simulated/path/P0022_synthetic_image.nii	/simulated/path/SIM-0022_GTV_segmentation.nii	/simulated/path/SIM-0022_CTV_segmentation.nii	/simulated/path/SIM-0022_PTV_segmentation.nii
SIM-0023	35	Female	56.9	167.2	Hypertension	null	Glioblastoma	High	IV	MRI	Anisotropic	Non-Contrast-Enhanced	Siemens	106.77	199.58	13.77	Single	75.2	Maximize Tumor Dose	DVH_P0023	/simulated/path/P0023_synthetic_image.nii	/simulated/path/SIM-0023_GTV_segmentation.nii	/simulated/path/SIM-0023_CTV_segmentation.nii	/simulated/path/SIM-0023_PTV_segmentation.nii
SIM-0024	19	Female	63	179.6	Cardiac Issues	null	Astrocytoma	Intermediate	I	PET	Isotropic	Contrast-Enhanced	Philips	60.05	58.19	239.7	Multi-Beam	43.22	Maximize Tumor Dose	DVH_P0024	/simulated/path/P0024_synthetic_image.nii	/simulated/path/SIM-0024_GTV_segmentation.nii	/simulated/path/SIM-0024_CTV_segmentation.nii	/simulated/path/SIM-0024_PTV_segmentation.nii
SIM-0025	68	Female	68.2	192.2	null	null	Astrocytoma	Low	II	CT	Isotropic	Non-Contrast-Enhanced	Philips	50.99	163.47	150.16	Single	60.55	Maximize Tumor Dose	DVH_P0025	/simulated/path/P0025_synthetic_image.nii	/simulated/path/SIM-0025_GTV_segmentation.nii	/simulated/path/SIM-0025_CTV_segmentation.nii	/simulated/path/SIM-0025_PTV_segmentation.nii
SIM-0026	23	Male	95.5	172.7	null	Radiotherapy	Astrocytoma	Low	I	PET	Anisotropic	Contrast-Enhanced	Siemens	75.93	49.45	187.4	Multi-Beam	37.78	Balanced	DVH_P0026	/simulated/path/P0026_synthetic_image.nii	/simulated/path/SIM-0026_GTV_segmentation.nii	/simulated/path/SIM-0026_CTV_segmentation.nii	/simulated/path/SIM-0026_PTV_segmentation.nii
SIM-0027	44	Male	78.7	176.1	Hypertension	Chemotherapy	Astrocytoma	Intermediate	II	MRI	Isotropic	Non-Contrast-Enhanced	Siemens	73.26	85.4	9.29	Single	29.45	Organ-Sparing	DVH_P0027	/simulated/path/P0027_synthetic_image.nii	/simulated/path/SIM-0027_GTV_segmentation.nii	/simulated/path/SIM-0027_CTV_segmentation.nii	/simulated/path/SIM-0027_PTV_segmentation.nii
SIM-0028	31	Male	86.5	163.9	Cancer History	Surgery	Glioblastoma	Low	IV	PET	Isotropic	Contrast-Enhanced	Siemens	83.68	105.61	244.9	Single	94.59	Maximize Tumor Dose	DVH_P0028	/simulated/path/P0028_synthetic_image.nii	/simulated/path/SIM-0028_GTV_segmentation.nii	/simulated/path/SIM-0028_CTV_segmentation.nii	/simulated/path/SIM-0028_PTV_segmentation.nii
SIM-0029	49	Female	77	160.1	Hypertension	null	Meningioma	High	IV	CT	Anisotropic	Contrast-Enhanced	Philips	63.73	107.81	94.39	Single	41.72	Balanced	DVH_P0029	/simulated/path/P0029_synthetic_image.nii	/simulated/path/SIM-0029_GTV_segmentation.nii	/simulated/path/SIM-0029_CTV_segmentation.nii	/simulated/path/SIM-0029_PTV_segmentation.nii
SIM-0030	68	Female	61.9	187.3	Cardiac Issues	Chemotherapy	Meningioma	Low	I	PET	Anisotropic	Non-Contrast-Enhanced	Philips	33.95	143.26	220.76	Single	56.67	Organ-Sparing	DVH_P0030	/simulated/path/P0030_synthetic_image.nii	/simulated/path/SIM-0030_GTV_segmentation.nii	/simulated/path/SIM-0030_CTV_segmentation.nii	/simulated/path/SIM-0030_PTV_segmentation.nii
SIM-0031	35	Male	66.7	197.6	Hypertension	null	Glioblastoma	High	IV	CT	Anisotropic	Non-Contrast-Enhanced	Siemens	126.21	141.08	243.46	Multi-Beam	84.85	Balanced	DVH_P0031	/simulated/path/P0031_synthetic_image.nii	/simulated/path/SIM-0031_GTV_segmentation.nii	/simulated/path/SIM-0031_CTV_segmentation.nii	/simulated/path/SIM-0031_PTV_segmentation.nii
SIM-0032	43	Male	64	197.2	Cardiac Issues	Chemotherapy	Metastatic	Intermediate	IV	MRI	Anisotropic	Contrast-Enhanced	Philips	40.67	5.38	184.47	Multi-Beam	27.81	Balanced	DVH_P0032	/simulated/path/P0032_synthetic_image.nii	/simulated/path/SIM-0032_GTV_segmentation.nii	/simulated/path/SIM-0032_CTV_segmentation.nii	/simulated/path/SIM-0032_PTV_segmentation.nii
SIM-0033	27	Female	99.2	189.3	null	null	Glioblastoma	Intermediate	IV	PET	Anisotropic	Contrast-Enhanced	GE	76.59	40.94	95.54	Single	95.33	Organ-Sparing	DVH_P0033	/simulated/path/P0033_synthetic_image.nii	/simulated/path/SIM-0033_GTV_segmentation.nii	/simulated/path/SIM-0033_CTV_segmentation.nii	/simulated/path/SIM-0033_PTV_segmentation.nii
SIM-0034	22	Male	92.1	193.1	Cancer History	Chemotherapy	Astrocytoma	Intermediate	II	PET	Isotropic	Contrast-Enhanced	Siemens	84.21	136.68	19.85	Multi-Beam	90.73	Balanced	DVH_P0034	/simulated/path/P0034_synthetic_image.nii	/simulated/path/SIM-0034_GTV_segmentation.nii	/simulated/path/SIM-0034_CTV_segmentation.nii	/simulated/path/SIM-0034_PTV_segmentation.nii
SIM-0035	20	Female	68.2	181.9	Cancer History	Surgery	Metastatic	High	III	MRI	Anisotropic	Contrast-Enhanced	Philips	52.73	26.8	187.41	Multi-Beam	10.15	Maximize Tumor Dose	DVH_P0035	/simulated/path/P0035_synthetic_image.nii	/simulated/path/SIM-0035_GTV_segmentation.nii	/simulated/path/SIM-0035_CTV_segmentation.nii	/simulated/path/SIM-0035_PTV_segmentation.nii
SIM-0036	29	Male	98.8	150.9	Diabetes	Surgery	Meningioma	Intermediate	II	PET	Isotropic	Non-Contrast-Enhanced	Siemens	20.58	175.93	163.29	Multi-Beam	74.16	Balanced	DVH_P0036	/simulated/path/P0036_synthetic_image.nii	/simulated/path/SIM-0036_GTV_segmentation.nii	/simulated/path/SIM-0036_CTV_segmentation.nii	/simulated/path/SIM-0036_PTV_segmentation.nii
SIM-0037	31	Male	71.8	165.4	Hypertension	Surgery	Meningioma	Intermediate	II	CT	Anisotropic	Non-Contrast-Enhanced	Philips	77.7	42.44	65.02	Single	81.99	Balanced	DVH_P0037	/simulated/path/P0037_synthetic_image.nii	/simulated/path/SIM-0037_GTV_segmentation.nii	/simulated/path/SIM-0037_CTV_segmentation.nii	/simulated/path/SIM-0037_PTV_segmentation.nii
SIM-0038	82	Female	52.1	157.5	Cardiac Issues	Radiotherapy	Meningioma	Low	III	PET	Isotropic	Non-Contrast-Enhanced	Philips	118.59	66.24	149.08	Single	53.17	Balanced	DVH_P0038	/simulated/path/P0038_synthetic_image.nii	/simulated/path/SIM-0038_GTV_segmentation.nii	/simulated/path/SIM-0038_CTV_segmentation.nii	/simulated/path/SIM-0038_PTV_segmentation.nii
SIM-0039	54	Male	64.2	183	Hypertension	null	Astrocytoma	High	IV	PET	Isotropic	Non-Contrast-Enhanced	Philips	21.8	80.61	125.32	Single	23.05	Balanced	DVH_P0039	/simulated/path/P0039_synthetic_image.nii	/simulated/path/SIM-0039_GTV_segmentation.nii	/simulated/path/SIM-0039_CTV_segmentation.nii	/simulated/path/SIM-0039_PTV_segmentation.nii
SIM-0040	60	Male	52.9	163.8	Hypertension	Radiotherapy	Meningioma	Low	III	CT	Isotropic	Contrast-Enhanced	Siemens	62.56	56.16	78.17	Single	49.33	Maximize Tumor Dose	DVH_P0040	/simulated/path/P0040_synthetic_image.nii	/simulated/path/SIM-0040_GTV_segmentation.nii	/simulated/path/SIM-0040_CTV_segmentation.nii	/simulated/path/SIM-0040_PTV_segmentation.nii
SIM-0041	76	Female	50.8	169.6	null	Surgery	Metastatic	Intermediate	III	PET	Anisotropic	Non-Contrast-Enhanced	GE	129.85	36.4	90.28	Multi-Beam	29.64	Balanced	DVH_P0041	/simulated/path/P0041_synthetic_image.nii	/simulated/path/SIM-0041_GTV_segmentation.nii	/simulated/path/SIM-0041_CTV_segmentation.nii	/simulated/path/SIM-0041_PTV_segmentation.nii
SIM-0042	70	Female	56.7	167.5	Cancer History	Surgery	Meningioma	High	II	MRI	Anisotropic	Contrast-Enhanced	GE	108.36	105.18	130.47	Single	23.94	Maximize Tumor Dose	DVH_P0042	/simulated/path/P0042_synthetic_image.nii	/simulated/path/SIM-0042_GTV_segmentation.nii	/simulated/path/SIM-0042_CTV_segmentation.nii	/simulated/path/SIM-0042_PTV_segmentation.nii
SIM-0043	33	Female	99	162.6	Diabetes	Radiotherapy	Metastatic	High	II	PET	Isotropic	Non-Contrast-Enhanced	GE	139.08	6.3	100.46	Single	94.65	Balanced	DVH_P0043	/simulated/path/P0043_synthetic_image.nii	/simulated/path/SIM-0043_GTV_segmentation.nii	/simulated/path/SIM-0043_CTV_segmentation.nii	/simulated/path/SIM-0043_PTV_segmentation.nii
SIM-0044	26	Female	63.7	165.7	Diabetes	Chemotherapy	Meningioma	Low	I	MRI	Anisotropic	Non-Contrast-Enhanced	GE	127.99	59.49	123.04	Single	50.13	Maximize Tumor Dose	DVH_P0044	/simulated/path/P0044_synthetic_image.nii	/simulated/path/SIM-0044_GTV_segmentation.nii	/simulated/path/SIM-0044_CTV_segmentation.nii	/simulated/path/SIM-0044_PTV_segmentation.nii
SIM-0045	44	Male	84.3	194	Cancer History	Surgery	Glioblastoma	Intermediate	I	CT	Anisotropic	Contrast-Enhanced	Philips	46.37	96.28	90.87	Single	57.6	Maximize Tumor Dose	DVH_P0045	/simulated/path/P0045_synthetic_image.nii	/simulated/path/SIM-0045_GTV_segmentation.nii	/simulated/path/SIM-0045_CTV_segmentation.nii	/simulated/path/SIM-0045_PTV_segmentation.nii
SIM-0046	74	Male	93.9	190.9	Diabetes	Surgery	Metastatic	Intermediate	III	CT	Isotropic	Non-Contrast-Enhanced	Philips	67.18	124.81	44.23	Multi-Beam	35.15	Balanced	DVH_P0046	/simulated/path/P0046_synthetic_image.nii	/simulated/path/SIM-0046_GTV_segmentation.nii	/simulated/path/SIM-0046_CTV_segmentation.nii	/simulated/path/SIM-0046_PTV_segmentation.nii
SIM-0047	69	Female	99	176.2	Cancer History	null	Astrocytoma	Low	I	PET	Anisotropic	Contrast-Enhanced	GE	66.22	95.13	29.16	Multi-Beam	34.8	Balanced	DVH_P0047	/simulated/path/P0047_synthetic_image.nii	/simulated/path/SIM-0047_GTV_segmentation.nii	/simulated/path/SIM-0047_CTV_segmentation.nii	/simulated/path/SIM-0047_PTV_segmentation.nii
SIM-0048	76	Male	73.2	159.7	Cardiac Issues	null	Astrocytoma	Low	II	MRI	Anisotropic	Contrast-Enhanced	Siemens	146.54	53.66	188.28	Multi-Beam	51.56	Organ-Sparing	DVH_P0048	/simulated/path/P0048_synthetic_image.nii	/simulated/path/SIM-0048_GTV_segmentation.nii	/simulated/path/SIM-0048_CTV_segmentation.nii	/simulated/path/SIM-0048_PTV_segmentation.nii
SIM-0049	19	Female	63.6	166.4	Cancer History	null	Astrocytoma	Low	II	PET	Isotropic	Contrast-Enhanced	Philips	132.27	184.09	37.52	Single	87.31	Organ-Sparing	DVH_P0049	/simulated/path/P0049_synthetic_image.nii	/simulated/path/SIM-0049_GTV_segmentation.nii	/simulated/path/SIM-0049_CTV_segmentation.nii	/simulated/path/SIM-0049_PTV_segmentation.nii
SIM-0050	84	Male	91.5	178.9	Cardiac Issues	Radiotherapy	Meningioma	Low	II	CT	Anisotropic	Non-Contrast-Enhanced	Philips	135.28	177.82	4.78	Single	63.92	Balanced	DVH_P0050	/simulated/path/P0050_synthetic_image.nii	/simulated/path/SIM-0050_GTV_segmentation.nii	/simulated/path/SIM-0050_CTV_segmentation.nii	/simulated/path/SIM-0050_PTV_segmentation.nii
SIM-0051	77	Male	59.1	174	Cancer History	Chemotherapy	Meningioma	Low	II	CT	Isotropic	Non-Contrast-Enhanced	Philips	135.19	68.54	40.06	Multi-Beam	71.74	Organ-Sparing	DVH_P0051	/simulated/path/P0051_synthetic_image.nii	/simulated/path/SIM-0051_GTV_segmentation.nii	/simulated/path/SIM-0051_CTV_segmentation.nii	/simulated/path/SIM-0051_PTV_segmentation.nii
SIM-0052	88	Female	55.5	198.1	null	Radiotherapy	Astrocytoma	Intermediate	III	MRI	Anisotropic	Contrast-Enhanced	Siemens	34.02	60.67	125.88	Single	22.88	Organ-Sparing	DVH_P0052	/simulated/path/P0052_synthetic_image.nii	/simulated/path/SIM-0052_GTV_segmentation.nii	/simulated/path/SIM-0052_CTV_segmentation.nii	/simulated/path/SIM-0052_PTV_segmentation.nii
SIM-0053	89	Female	98.2	188.8	Cancer History	null	Glioblastoma	High	III	PET	Anisotropic	Non-Contrast-Enhanced	Siemens	52.94	28.25	14.13	Single	92.06	Balanced	DVH_P0053	/simulated/path/P0053_synthetic_image.nii	/simulated/path/SIM-0053_GTV_segmentation.nii	/simulated/path/SIM-0053_CTV_segmentation.nii	/simulated/path/SIM-0053_PTV_segmentation.nii
SIM-0054	73	Female	81.1	173	null	Surgery	Metastatic	High	III	CT	Isotropic	Contrast-Enhanced	Philips	83.35	106.21	184.49	Single	11.64	Maximize Tumor Dose	DVH_P0054	/simulated/path/P0054_synthetic_image.nii	/simulated/path/SIM-0054_GTV_segmentation.nii	/simulated/path/SIM-0054_CTV_segmentation.nii	/simulated/path/SIM-0054_PTV_segmentation.nii
SIM-0055	28	Female	70.3	195	Cancer History	Radiotherapy	Meningioma	Low	I	CT	Anisotropic	Non-Contrast-Enhanced	Philips	116.77	125.71	192.23	Multi-Beam	31.99	Balanced	DVH_P0055	/simulated/path/P0055_synthetic_image.nii	/simulated/path/SIM-0055_GTV_segmentation.nii	/simulated/path/SIM-0055_CTV_segmentation.nii	/simulated/path/SIM-0055_PTV_segmentation.nii
SIM-0056	18	Male	98	158.7	null	Radiotherapy	Glioblastoma	High	III	PET	Anisotropic	Contrast-Enhanced	Siemens	132.09	40.16	141.99	Single	79.51	Balanced	DVH_P0056	/simulated/path/P0056_synthetic_image.nii	/simulated/path/SIM-0056_GTV_segmentation.nii	/simulated/path/SIM-0056_CTV_segmentation.nii	/simulated/path/SIM-0056_PTV_segmentation.nii
SIM-0057	38	Female	87	172.2	Cardiac Issues	null	Metastatic	High	I	CT	Isotropic	Non-Contrast-Enhanced	GE	20.23	185.05	208.51	Single	44.55	Balanced	DVH_P0057	/simulated/path/P0057_synthetic_image.nii	/simulated/path/SIM-0057_GTV_segmentation.nii	/simulated/path/SIM-0057_CTV_segmentation.nii	/simulated/path/SIM-0057_PTV_segmentation.nii
SIM-0058	35	Male	85.6	169.3	Hypertension	Surgery	Metastatic	Intermediate	IV	CT	Anisotropic	Contrast-Enhanced	Philips	55.63	43.07	147.32	Single	79.82	Organ-Sparing	DVH_P0058	/simulated/path/P0058_synthetic_image.nii	/simulated/path/SIM-0058_GTV_segmentation.nii	/simulated/path/SIM-0058_CTV_segmentation.nii	/simulated/path/SIM-0058_PTV_segmentation.nii
SIM-0059	39	Female	70.9	197.2	Hypertension	null	Metastatic	Intermediate	II	CT	Isotropic	Contrast-Enhanced	Philips	70.56	149.6	5.76	Multi-Beam	96.46	Organ-Sparing	DVH_P0059	/simulated/path/P0059_synthetic_image.nii	/simulated/path/SIM-0059_GTV_segmentation.nii	/simulated/path/SIM-0059_CTV_segmentation.nii	/simulated/path/SIM-0059_PTV_segmentation.nii
SIM-0060	55	Male	78.5	159.5	null	null	Glioblastoma	Low	II	MRI	Isotropic	Contrast-Enhanced	GE	81.38	157.76	7.77	Single	77.81	Organ-Sparing	DVH_P0060	/simulated/path/P0060_synthetic_image.nii	/simulated/path/SIM-0060_GTV_segmentation.nii	/simulated/path/SIM-0060_CTV_segmentation.nii	/simulated/path/SIM-0060_PTV_segmentation.nii
SIM-0061	33	Male	94.7	187.1	Cardiac Issues	null	Glioblastoma	High	I	CT	Anisotropic	Non-Contrast-Enhanced	GE	133.71	157.2	140.91	Multi-Beam	76.95	Organ-Sparing	DVH_P0061	/simulated/path/P0061_synthetic_image.nii	/simulated/path/SIM-0061_GTV_segmentation.nii	/simulated/path/SIM-0061_CTV_segmentation.nii	/simulated/path/SIM-0061_PTV_segmentation.nii
SIM-0062	67	Female	62.1	170.1	Hypertension	Radiotherapy	Astrocytoma	Intermediate	III	CT	Isotropic	Contrast-Enhanced	GE	140.39	183.89	6.34	Single	94.89	Balanced	DVH_P0062	/simulated/path/P0062_synthetic_image.nii	/simulated/path/SIM-0062_GTV_segmentation.nii	/simulated/path/SIM-0062_CTV_segmentation.nii	/simulated/path/SIM-0062_PTV_segmentation.nii
SIM-0063	32	Female	80.1	196.1	null	null	Astrocytoma	High	II	PET	Anisotropic	Contrast-Enhanced	Siemens	75.61	105.58	232.89	Single	38.73	Organ-Sparing	DVH_P0063	/simulated/path/P0063_synthetic_image.nii	/simulated/path/SIM-0063_GTV_segmentation.nii	/simulated/path/SIM-0063_CTV_segmentation.nii	/simulated/path/SIM-0063_PTV_segmentation.nii
SIM-0064	23	Female	89.9	190	Cancer History	Surgery	Meningioma	Intermediate	I	CT	Anisotropic	Contrast-Enhanced	GE	85.25	127.48	186.6	Multi-Beam	34.62	Maximize Tumor Dose	DVH_P0064	/simulated/path/P0064_synthetic_image.nii	/simulated/path/SIM-0064_GTV_segmentation.nii	/simulated/path/SIM-0064_CTV_segmentation.nii	/simulated/path/SIM-0064_PTV_segmentation.nii
SIM-0065	40	Female	87.8	152.6	null	Surgery	Astrocytoma	Intermediate	II	CT	Isotropic	Non-Contrast-Enhanced	Siemens	92.33	26.39	154.98	Multi-Beam	95.44	Balanced	DVH_P0065	/simulated/path/P0065_synthetic_image.nii	/simulated/path/SIM-0065_GTV_segmentation.nii	/simulated/path/SIM-0065_CTV_segmentation.nii	/simulated/path/SIM-0065_PTV_segmentation.nii
SIM-0066	40	Female	70.7	191.9	Hypertension	Radiotherapy	Meningioma	Intermediate	III	CT	Anisotropic	Contrast-Enhanced	Philips	2.2	159.72	31.51	Multi-Beam	10.31	Balanced	DVH_P0066	/simulated/path/P0066_synthetic_image.nii	/simulated/path/SIM-0066_GTV_segmentation.nii	/simulated/path/SIM-0066_CTV_segmentation.nii	/simulated/path/SIM-0066_PTV_segmentation.nii
SIM-0067	89	Male	84.5	188.3	Hypertension	Chemotherapy	Meningioma	High	III	MRI	Isotropic	Contrast-Enhanced	Siemens	143.83	137.42	137.21	Multi-Beam	85.42	Maximize Tumor Dose	DVH_P0067	/simulated/path/P0067_synthetic_image.nii	/simulated/path/SIM-0067_GTV_segmentation.nii	/simulated/path/SIM-0067_CTV_segmentation.nii	/simulated/path/SIM-0067_PTV_segmentation.nii
SIM-0068	81	Male	76.2	153.8	Diabetes	Surgery	Astrocytoma	Intermediate	IV	MRI	Anisotropic	Contrast-Enhanced	Siemens	45.64	69.44	103.65	Single	16.97	Organ-Sparing	DVH_P0068	/simulated/path/P0068_synthetic_image.nii	/simulated/path/SIM-0068_GTV_segmentation.nii	/simulated/path/SIM-0068_CTV_segmentation.nii	/simulated/path/SIM-0068_PTV_segmentation.nii
SIM-0069	65	Male	59.5	166.8	Diabetes	Surgery	Metastatic	Low	II	CT	Anisotropic	Non-Contrast-Enhanced	Philips	60.52	63.15	68.99	Single	15.51	Maximize Tumor Dose	DVH_P0069	/simulated/path/P0069_synthetic_image.nii	/simulated/path/SIM-0069_GTV_segmentation.nii	/simulated/path/SIM-0069_CTV_segmentation.nii	/simulated/path/SIM-0069_PTV_segmentation.nii
SIM-0070	89	Female	73.5	188.7	Cardiac Issues	null	Glioblastoma	Low	I	MRI	Isotropic	Non-Contrast-Enhanced	Philips	92.67	89.49	217.57	Single	36.47	Organ-Sparing	DVH_P0070	/simulated/path/P0070_synthetic_image.nii	/simulated/path/SIM-0070_GTV_segmentation.nii	/simulated/path/SIM-0070_CTV_segmentation.nii	/simulated/path/SIM-0070_PTV_segmentation.nii
SIM-0071	58	Male	59.3	150.4	Diabetes	Surgery	Glioblastoma	High	IV	MRI	Isotropic	Contrast-Enhanced	Philips	82.03	24.07	181.84	Single	75.56	Maximize Tumor Dose	DVH_P0071	/simulated/path/P0071_synthetic_image.nii	/simulated/path/SIM-0071_GTV_segmentation.nii	/simulated/path/SIM-0071_CTV_segmentation.nii	/simulated/path/SIM-0071_PTV_segmentation.nii
SIM-0072	65	Female	87.6	192.1	Hypertension	null	Glioblastoma	Intermediate	IV	PET	Anisotropic	Non-Contrast-Enhanced	Philips	49.39	182.64	44.52	Single	43.3	Maximize Tumor Dose	DVH_P0072	/simulated/path/P0072_synthetic_image.nii	/simulated/path/SIM-0072_GTV_segmentation.nii	/simulated/path/SIM-0072_CTV_segmentation.nii	/simulated/path/SIM-0072_PTV_segmentation.nii
SIM-0073	41	Female	79.4	171.3	null	Surgery	Astrocytoma	High	I	MRI	Anisotropic	Contrast-Enhanced	Siemens	108.26	100.87	32.06	Single	20.78	Balanced	DVH_P0073	/simulated/path/P0073_synthetic_image.nii	/simulated/path/SIM-0073_GTV_segmentation.nii	/simulated/path/SIM-0073_CTV_segmentation.nii	/simulated/path/SIM-0073_PTV_segmentation.nii
SIM-0074	18	Male	92.8	197	Diabetes	Surgery	Glioblastoma	High	I	CT	Isotropic	Contrast-Enhanced	Siemens	117.47	32.95	223.19	Multi-Beam	37.62	Organ-Sparing	DVH_P0074	/simulated/path/P0074_synthetic_image.nii	/simulated/path/SIM-0074_GTV_segmentation.nii	/simulated/path/SIM-0074_CTV_segmentation.nii	/simulated/path/SIM-0074_PTV_segmentation.nii
SIM-0075	55	Male	56.3	198.1	Hypertension	Surgery	Metastatic	High	III	CT	Anisotropic	Non-Contrast-Enhanced	Siemens	32.34	45.99	152.73	Single	58.59	Organ-Sparing	DVH_P0075	/simulated/path/P0075_synthetic_image.nii	/simulated/path/SIM-0075_GTV_segmentation.nii	/simulated/path/SIM-0075_CTV_segmentation.nii	/simulated/path/SIM-0075_PTV_segmentation.nii
SIM-0076	20	Male	83.3	168.9	Hypertension	null	Meningioma	Intermediate	III	CT	Isotropic	Contrast-Enhanced	Siemens	78.95	138.23	103.12	Single	48.03	Organ-Sparing	DVH_P0076	/simulated/path/P0076_synthetic_image.nii	/simulated/path/SIM-0076_GTV_segmentation.nii	/simulated/path/SIM-0076_CTV_segmentation.nii	/simulated/path/SIM-0076_PTV_segmentation.nii
SIM-0077	67	Male	76.1	187.5	Cardiac Issues	Radiotherapy	Astrocytoma	Low	I	MRI	Anisotropic	Non-Contrast-Enhanced	Philips	25.19	187.18	162.9	Multi-Beam	91.95	Organ-Sparing	DVH_P0077	/simulated/path/P0077_synthetic_image.nii	/simulated/path/SIM-0077_GTV_segmentation.nii	/simulated/path/SIM-0077_CTV_segmentation.nii	/simulated/path/SIM-0077_PTV_segmentation.nii
SIM-0078	53	Female	92.8	153.3	Hypertension	Chemotherapy	Metastatic	High	IV	MRI	Isotropic	Contrast-Enhanced	Philips	133.13	135.98	146.62	Multi-Beam	11.43	Balanced	DVH_P0078	/simulated/path/P0078_synthetic_image.nii	/simulated/path/SIM-0078_GTV_segmentation.nii	/simulated/path/SIM-0078_CTV_segmentation.nii	/simulated/path/SIM-0078_PTV_segmentation.nii
SIM-0079	20	Female	80.2	155	null	Surgery	Glioblastoma	Intermediate	I	MRI	Anisotropic	Non-Contrast-Enhanced	Philips	142.68	146.66	20.08	Single	11.93	Maximize Tumor Dose	DVH_P0079	/simulated/path/P0079_synthetic_image.nii	/simulated/path/SIM-0079_GTV_segmentation.nii	/simulated/path/SIM-0079_CTV_segmentation.nii	/simulated/path/SIM-0079_PTV_segmentation.nii
SIM-0080	67	Female	96.5	174.4	Diabetes	Surgery	Astrocytoma	High	III	CT	Isotropic	Contrast-Enhanced	Philips	100.93	172.39	170.37	Single	51.22	Balanced	DVH_P0080	/simulated/path/P0080_synthetic_image.nii	/simulated/path/SIM-0080_GTV_segmentation.nii	/simulated/path/SIM-0080_CTV_segmentation.nii	/simulated/path/SIM-0080_PTV_segmentation.nii
SIM-0081	18	Male	59.2	158.8	null	Chemotherapy	Meningioma	Intermediate	II	CT	Isotropic	Non-Contrast-Enhanced	GE	5.57	141.21	25.8	Multi-Beam	18.11	Maximize Tumor Dose	DVH_P0081	/simulated/path/P0081_synthetic_image.nii	/simulated/path/SIM-0081_GTV_segmentation.nii	/simulated/path/SIM-0081_CTV_segmentation.nii	/simulated/path/SIM-0081_PTV_segmentation.nii
SIM-0082	74	Male	61.5	166.4	Cancer History	Surgery	Meningioma	High	IV	PET	Isotropic	Contrast-Enhanced	Siemens	87.57	82.4	49.67	Single	27.82	Maximize Tumor Dose	DVH_P0082	/simulated/path/P0082_synthetic_image.nii	/simulated/path/SIM-0082_GTV_segmentation.nii	/simulated/path/SIM-0082_CTV_segmentation.nii	/simulated/path/SIM-0082_PTV_segmentation.nii
SIM-0083	43	Female	82.1	176.4	Diabetes	null	Metastatic	Intermediate	IV	CT	Isotropic	Contrast-Enhanced	Philips	49.5	20.27	11.02	Multi-Beam	61.11	Organ-Sparing	DVH_P0083	/simulated/path/P0083_synthetic_image.nii	/simulated/path/SIM-0083_GTV_segmentation.nii	/simulated/path/SIM-0083_CTV_segmentation.nii	/simulated/path/SIM-0083_PTV_segmentation.nii
SIM-0084	51	Male	56.3	198.2	null	Radiotherapy	Metastatic	Intermediate	I	PET	Isotropic	Contrast-Enhanced	GE	39.74	129.25	226.55	Single	66.46	Balanced	DVH_P0084	/simulated/path/P0084_synthetic_image.nii	/simulated/path/SIM-0084_GTV_segmentation.nii	/simulated/path/SIM-0084_CTV_segmentation.nii	/simulated/path/SIM-0084_PTV_segmentation.nii
SIM-0085	59	Female	92.7	172.2	Diabetes	Radiotherapy	Glioblastoma	Low	IV	CT	Anisotropic	Non-Contrast-Enhanced	GE	16.08	98.36	104.41	Single	51.51	Maximize Tumor Dose	DVH_P0085	/simulated/path/P0085_synthetic_image.nii	/simulated/path/SIM-0085_GTV_segmentation.nii	/simulated/path/SIM-0085_CTV_segmentation.nii	/simulated/path/SIM-0085_PTV_segmentation.nii
SIM-0086	82	Female	86.1	162.5	Diabetes	null	Glioblastoma	High	II	MRI	Anisotropic	Contrast-Enhanced	Philips	149.16	102.93	55.77	Multi-Beam	20.16	Balanced	DVH_P0086	/simulated/path/P0086_synthetic_image.nii	/simulated/path/SIM-0086_GTV_segmentation.nii	/simulated/path/SIM-0086_CTV_segmentation.nii	/simulated/path/SIM-0086_PTV_segmentation.nii
SIM-0087	88	Male	66.4	182.8	Diabetes	Surgery	Metastatic	High	II	CT	Isotropic	Non-Contrast-Enhanced	Philips	19.29	27.17	246.38	Multi-Beam	27.49	Maximize Tumor Dose	DVH_P0087	/simulated/path/P0087_synthetic_image.nii	/simulated/path/SIM-0087_GTV_segmentation.nii	/simulated/path/SIM-0087_CTV_segmentation.nii	/simulated/path/SIM-0087_PTV_segmentation.nii
SIM-0088	44	Female	97.3	199.8	Cancer History	null	Metastatic	Low	II	CT	Isotropic	Non-Contrast-Enhanced	Philips	104.66	163.44	221.45	Multi-Beam	52.58	Balanced	DVH_P0088	/simulated/path/P0088_synthetic_image.nii	/simulated/path/SIM-0088_GTV_segmentation.nii	/simulated/path/SIM-0088_CTV_segmentation.nii	/simulated/path/SIM-0088_PTV_segmentation.nii
SIM-0089	62	Female	95.6	175.9	Diabetes	Chemotherapy	Glioblastoma	High	II	CT	Anisotropic	Contrast-Enhanced	GE	121.92	79.51	181.99	Single	14.42	Maximize Tumor Dose	DVH_P0089	/simulated/path/P0089_synthetic_image.nii	/simulated/path/SIM-0089_GTV_segmentation.nii	/simulated/path/SIM-0089_CTV_segmentation.nii	/simulated/path/SIM-0089_PTV_segmentation.nii
SIM-0090	52	Male	61.8	181	null	Radiotherapy	Metastatic	Intermediate	II	PET	Isotropic	Non-Contrast-Enhanced	Philips	102.11	128.62	46.73	Single	62.59	Organ-Sparing	DVH_P0090	/simulated/path/P0090_synthetic_image.nii	/simulated/path/SIM-0090_GTV_segmentation.nii	/simulated/path/SIM-0090_CTV_segmentation.nii	/simulated/path/SIM-0090_PTV_segmentation.nii
SIM-0091	83	Female	82.7	180.3	Cancer History	Surgery	Astrocytoma	Intermediate	IV	MRI	Isotropic	Contrast-Enhanced	GE	97.2	183.32	161.93	Multi-Beam	65.17	Maximize Tumor Dose	DVH_P0091	/simulated/path/P0091_synthetic_image.nii	/simulated/path/SIM-0091_GTV_segmentation.nii	/simulated/path/SIM-0091_CTV_segmentation.nii	/simulated/path/SIM-0091_PTV_segmentation.nii
SIM-0092	43	Male	82	157.5	Cardiac Issues	Radiotherapy	Glioblastoma	Low	IV	PET	Anisotropic	Contrast-Enhanced	Philips	38.43	66.57	47.83	Multi-Beam	79.09	Organ-Sparing	DVH_P0092	/simulated/path/P0092_synthetic_image.nii	/simulated/path/SIM-0092_GTV_segmentation.nii	/simulated/path/SIM-0092_CTV_segmentation.nii	/simulated/path/SIM-0092_PTV_segmentation.nii
SIM-0093	63	Female	51.4	165.3	null	null	Metastatic	Intermediate	IV	PET	Isotropic	Contrast-Enhanced	GE	80.17	55.12	97.17	Multi-Beam	31.63	Organ-Sparing	DVH_P0093	/simulated/path/P0093_synthetic_image.nii	/simulated/path/SIM-0093_GTV_segmentation.nii	/simulated/path/SIM-0093_CTV_segmentation.nii	/simulated/path/SIM-0093_PTV_segmentation.nii
SIM-0094	33	Female	55.8	155.2	Hypertension	null	Glioblastoma	Low	I	PET	Isotropic	Contrast-Enhanced	Siemens	71.57	165.54	247.41	Multi-Beam	44.94	Maximize Tumor Dose	DVH_P0094	/simulated/path/P0094_synthetic_image.nii	/simulated/path/SIM-0094_GTV_segmentation.nii	/simulated/path/SIM-0094_CTV_segmentation.nii	/simulated/path/SIM-0094_PTV_segmentation.nii
SIM-0095	38	Male	69.9	192.1	Diabetes	Radiotherapy	Meningioma	Intermediate	II	CT	Anisotropic	Non-Contrast-Enhanced	GE	66.24	73.44	119.01	Multi-Beam	40.17	Balanced	DVH_P0095	/simulated/path/P0095_synthetic_image.nii	/simulated/path/SIM-0095_GTV_segmentation.nii	/simulated/path/SIM-0095_CTV_segmentation.nii	/simulated/path/SIM-0095_PTV_segmentation.nii
SIM-0096	24	Male	82.4	166.6	null	null	Meningioma	Intermediate	IV	MRI	Anisotropic	Non-Contrast-Enhanced	GE	105.15	10.4	38.3	Single	95.66	Organ-Sparing	DVH_P0096	/simulated/path/P0096_synthetic_image.nii	/simulated/path/SIM-0096_GTV_segmentation.nii	/simulated/path/SIM-0096_CTV_segmentation.nii	/simulated/path/SIM-0096_PTV_segmentation.nii
SIM-0097	71	Male	70.2	183.3	Hypertension	Radiotherapy	Glioblastoma	Low	IV	MRI	Anisotropic	Non-Contrast-Enhanced	Philips	100.77	101.83	205.57	Single	86.4	Balanced	DVH_P0097	/simulated/path/P0097_synthetic_image.nii	/simulated/path/SIM-0097_GTV_segmentation.nii	/simulated/path/SIM-0097_CTV_segmentation.nii	/simulated/path/SIM-0097_PTV_segmentation.nii
SIM-0098	80	Female	92.1	183.4	Hypertension	Chemotherapy	Meningioma	Low	I	CT	Isotropic	Contrast-Enhanced	GE	52.86	42.88	123.36	Single	48.24	Balanced	DVH_P0098	/simulated/path/P0098_synthetic_image.nii	/simulated/path/SIM-0098_GTV_segmentation.nii	/simulated/path/SIM-0098_CTV_segmentation.nii	/simulated/path/SIM-0098_PTV_segmentation.nii
SIM-0099	26	Female	93.7	189.1	Cardiac Issues	Surgery	Meningioma	Low	I	CT	Isotropic	Non-Contrast-Enhanced	GE	121.08	165.03	225.62	Single	14.84	Maximize Tumor Dose	DVH_P0099	/simulated/path/P0099_synthetic_image.nii	/simulated/path/SIM-0099_GTV_segmentation.nii	/simulated/path/SIM-0099_CTV_segmentation.nii	/simulated/path/SIM-0099_PTV_segmentation.nii
SIM-0100	22	Female	93.9	177.8	Diabetes	null	Metastatic	High	IV	PET	Isotropic	Non-Contrast-Enhanced	Siemens	137.96	190.36	60.65	Multi-Beam	82.81	Maximize Tumor Dose	DVH_P0100	/simulated/path/P0100_synthetic_image.nii	/simulated/path/SIM-0100_GTV_segmentation.nii	/simulated/path/SIM-0100_CTV_segmentation.nii	/simulated/path/SIM-0100_PTV_segmentation.nii

End of preview. Expand in Data Studio

🎯 Stereotactic Radiosurgery Dataset (SRS)

🎯 Overview

The Stereotactic Radiosurgery Dataset is tailored for research in advanced AI applications for Stereotactic Radiosurgery (SRS).

📊 Dataset Summary

Feature	Details
🏥 Clinical Data	400 patient records with demographic and medical history information.
🧠 Imaging Data	High-resolution CT, MRI, and PET scans with isotropic and anisotropic voxel sizes.
🎯 Tumor Segmentations	Segmentation paths for GTV, CTV, and PTV with inter-observer variability.
⚙️ Treatment Plans	Beam arrangements, dose distributions, DVHs, and optimization objectives.
📂 File Formats	Metadata in CSV and images/segmentations in NIfTI.

💡 Features

1. Clinical Data

Patient demographics: Age, gender, weight, height.
Medical history: Comorbidities, previous treatments.
Tumor details: Histology, grade, and stage.

2. Imaging Data

Modalities: CT, MRI, and PET.
Imaging protocols: Contrast-enhanced and non-contrast-enhanced scans.
Scanner metadata: Manufacturer and model.

3. Tumor Segmentation

Gross Tumor Volume (GTV), Clinical Target Volume (CTV), and Planning Target Volume (PTV).
Segmentation paths stored in NIfTI format.

4. Treatment Plans

Dose distributions, beam arrangements, and dose-volume histograms (DVHs).
Optimization goals: Tumor dose maximization and organ sparing.

🔍 Usage

This dataset supports multiple applications:

Automated Contouring: Train models for accurate tumor volume delineation.
Treatment Optimization: Develop algorithms for optimized treatment plans.
Patient Outcome Prediction: Research predictive analytics for treatment response.

🛠️ File Organization

Main CSV: Contains metadata for all patient cases.
Synthetic Images: Paths to synthetic CT, MRI, and PET scans.
Tumor Segmentations: Paths to NIfTI files for GTV, CTV, and PTV segmentations.
Simulated Paths: Placeholder paths simulate real-world usage scenarios.

🎨 Visual Example

Below is an example row from the dataset:

Feature	Example Value
Patient_ID	`SIM-0001`
Age	`36`
Imaging Modality	`CT`
Tumor Histology	`Meningioma`
GTV_Segmentation_Path	`/simulated/path/SIM-0001_GTV_segmentation.nii`
Beam Arrangements	`Single`
Dose Distributions (Gy)	`35.04`

📜 Citations

If you use this dataset, please cite it as follows:

💬 Contact

For questions, reach out to the dataset maintainer: A Taylor @ hf.co/taylor658

🔒 Licensing

This dataset is licensed under apache-2.0.

Downloads last month: 7

Size of downloaded dataset files:

141 kB

Size of the auto-converted Parquet files:

43.7 kB

Number of rows:

400